Abstract
Background
Immigrants from China and Africa have high rates of hepatitis B virus infection (HBV) and hepatocellular carcinoma (HCC); however, primary care physician (PCP) adherence to screening guidelines in at-risk communities is not well understood.
Methods
The New York City (NYC) neighborhood tabulation areas with the 25 greatest Chinese and African immigrant populations were determined based on US census data. The American Medical Association database was used to identify PCPs practicing in these neighborhoods. A Web-based survey designed to assess HBV and HCC knowledge and screening practices was distributed via e-mail to PCPs in these target areas.
Results
A total of 2072 physicians were contacted, and 109 responded to the survey, for a response rate of 5.3 %. Among responding physicians, 73 % report routinely testing immigrant patients for HBV. However, if a patient tests positive for HBV, only 68 % of providers recommend screening for HCC. Over a quarter of PCPs (27 %), failed to correctly state that antiviral therapy can lower the risk of developing HCC, and only 56 % correctly replied that screening for liver cancer improves survival. Of responders, only 54 % answered correctly that a 25-year-old patient from Africa with HBV should be screened for HCC, whereas 53 % answered incorrectly that a 25-year-old patient from China with HBV should be screened, demonstrating a lack of awareness of the different age of onset of liver cancer in the two groups. The most commonly reported barrier to offering both HBV testing and HCC screening was a “lack of clear guidelines.” Neither HBV nor HCC was among the top 3 health concerns of patients, as perceived by their physicians. There were no significant differences between provider responses in Chinese and African immigrant neighborhoods.
Conclusions
Providers serving Chinese and African immigrants in NYC often fail to recommend appropriate HBV and HCC screening. This appears to be due to significant gaps in provider knowledge and a lack of awareness of established screening guidelines. This study suggests the need for better distribution of existing guidelines to physicians serving immigrant-rich communities in order to improve HBV and HCC screening in high-risk individuals.
Similar content being viewed by others
Change history
26 January 2017
An erratum to this article has been published.
References
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–73.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44.
Colvin HM, Mitchell AE. Hepatitis and liver cancer: a National Strategy for prevention and control of hepatitis B and C. Washington, D.C.: The National Academies Press; 2010.
Shaughnessy AF. USPSTF recommendations for hepatitis B screening. Am Fam Physician. 2014;90(11):795.
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417–22.
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351(15):1521–31.
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–36.
Kew MC, Macerollo P. Effect of age on the etiologic role of the hepatitis B virus in hepatocellular carcinoma in blacks. Gastroenterology. 1988;94(2):439–42.
Kew MC, Marcus R, Geddes EW. Some characteristics of Mozambican Shangaans with primary hepatocellular cancer. S Afr Med J. 1977;51(10):306–9.
Bodle EE, Islam N, Kwon SC, Zojwalla N, Ahsan H, Senie RT. Cancer screening practices of Asian American physicians in New York City. J Immigr Minor Health. 2008;10(3):239–46.
Chu D, Yang JD, Lok AS, Tran T, Martins EB, Fagan E, et al. Hepatitis B screening and vaccination practices in asian american primary care. Gut Liver. 2013;7(4):450–7.
Braillon A. Hepatocellular carcinoma screening among hepatitis B-infected Asian Americans. J Viral Hepat. 2013;20(7):514.
Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat. 2012;19(8):594–600.
Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011;56(5):1516–23.
Kwon HT, Ma GX, Gold RS, Atkinson NL, Wang MQ. Primary care physicians' cancer screening recommendation practices and perceptions of cancer risk of Asian Americans. Asian Pac J Cancer Prev. 2013;14(3):1999–2004.
Adair R, Nwaneri O. Communicable disease in African immigrants in Minneapolis. Arch Intern Med. 1999;159(1):83–5.
Ugwu C, Varkey P, Bagniewski S, Lesnick T. Sero-epidemiology of hepatitis B among new refugees to Minnesota. J Immigr Minor Health. 2008;10(5):469–74.
Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158–68.
Gambino C. P., Trevelyan E. N., Fitzwater J. T. The Foreign-Born Population From Africa: 2008–2012. In: American Community Survey Briefs. U.S. Census Bureau. 2014. https://www.census.gov/content/dam/Census/library/publications/2014/acs/acsbr12-16.pdf. Accessed 20 Sep 2016.
Grieco E. M., Acosta Y. D., De la Cruz G. P., Gambino C., Gryn T., Larsen L. J., Trevelyan E. N., Walters, NP. The Foreign-Born Population in the United States: 2010. In: American Community Survey Reports. U.S. Census Bureau. 2012. https://www.census.gov/prod/2012pubs/acs-19.pdf. Accessed 20 Sep 2016.
New York City Census FactFinder. In: New York City Department of City Planning: 2010. http://maps.nyc.gov/census/. Accessed 20 Sep 2016.
McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000;32(4 Pt 1):842–6.
Lai CJ, Nguyen TT, Hwang J, Stewart SL, Kwan A, McPhee SJ. Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J Cancer Educ. 2007;22(1):37–41.
Nguyen TT, Gildengorin G, Truong A, McPhee SJ. Factors influencing physicians' screening behavior for liver cancer among high-risk patients. J Gen Intern Med. 2007;22(4):523–6.
Howlader N, N. A. Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). (2012). SEER Cancer statistics review, 1975–2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute.
Grulich AE, Swerdlow AJ, Head J, Marmot MG. Cancer mortality in African and Caribbean migrants to England and Wales. Br J Cancer. 1992;66(5):905–11.
Strong C, Lee S, Tanaka M, Juon HS. Ethnic differences in prevalence and barriers of HBV screening and vaccination among Asian Americans. J Community Health. 2012;37(5):1071–80.
Burman B, Mukhtar N, Toy B, Nguyen T, Chen A, Yu A, et al. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care. Dig Dis Sci. 2014;59(1):46–56.
Foster T, Hon H, Kanwal F, Han S, Spiegel B. Screening high risk individuals for hepatitis B: physician knowledge, attitudes, and beliefs. Dig Dis Sci. 2011;56(12):3471–87.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
We gratefully acknowledge that this study was supported by grant 1R03CA164546-01A1 from the National Cancer Institute.
Conflict of Interest
Authors Fitzgerald, Chao, Perumalswami, Feferman, and Sarpel declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Please note that this study was determined to have “exempt” status after formal consideration by our Institutional Review Board.
Additional information
The original version of this article was revised: The correct spelling of the third author’s family name is Feferman.
An erratum to this article is available at https://doi.org/10.1007/s40615-016-0331-z.
Rights and permissions
About this article
Cite this article
Fitzgerald, S., Chao, J., Feferman, Y. et al. Hepatitis B and Hepatocellular Carcinoma Screening Practices in Chinese and African Immigrant-Rich Neighborhoods in New York City. J. Racial and Ethnic Health Disparities 4, 928–935 (2017). https://doi.org/10.1007/s40615-016-0296-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40615-016-0296-y